Abstract
Maspin, a serin protease inhibitor is differentially expressed among different types of cancer. Only few data concerning the expression of maspin in ovarian cancer (OC) do exist. To find out if maspin could serve as an prognostic marker in OC patients; this study evaluates the maspin expression (ME) and its correlation to tumor clinical-pathological factors and survival.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
